*Emerging infections 8* is the latest in a series drawn from symposia at Infectious Diseases Society of America and Interscience Conference on Antimicrobial Agents and Chemotherapy meetings. Continuing in the tradition of earlier volumes, the book covers a range of eclectic topics (eg, *Klebsiella oxytoca* antibiotic-associated colitis), some of which may be little known to readers and rarely addressed, at least in depth, in standard textbooks. Many of the authors of the 20 chapters are not widely known experts but mid-career physicians, scientists, and public-health workers in front-line positions. This focuses the chapters more on practical than academic or theoretical issues, and gives them particular appeal to those who must deal directly with these diseases in their professional capacities.

Among the diseases addressed in *Emerging infections 8* are those of widespread and public-health importance (noroviruses, Japanese encephalitis, extensively drug-resistant tuberculosis); those that have re-emerged into public-health consciousness (chikungunya); those caused by novel agents (human bocaviruses and human parechoviruses); and those that require frequent updates and progress reports (meticillin-resistant *Staphylococcus aureus*, Rift Valley fever). An especially interesting chapter by Ian Lipkin and colleagues discusses "emerging" diagnostic tools and links modern criteria for establishing microbial disease aetiology to those of Henle, Klebs, and Koch in the early days of microbiology (1840--80). Other noteworthy subjects include immune reconstitution inflammatory syndrome, adenoviral infections in transplant recipients, novel coronaviruses, lyssaviruses, henipaviruses, *Streptococcus suis, Clostridium difficile*, non-*albicans Candida* spp infections, and pertussis.

A potential problem with a book reflecting the particular experiences of the authors is that individual chapters can seem unbalanced (eg, clinical emphasis that ignores important epidemiology). *Emerging infections 8* is not really suitable for students or scientists new to the subject. In treating specific emerging or re-emerging disease problems, it does not generally try to identify larger themes or perspectives, such as underlying mechanisms of emergence, mechanisms of host-switching, environmental and social determinants, or microbial evolution. But such information is generally available in the medical/scientific literature at large, and its omission here seems justifiable and probably necessary in the interest of reviewing several important emerging diseases.

The book will be of most value to practitioners and scientists who have access to the whole *Emerging infections* series, which covers many additional diseases, and to those studying specific and practical issues related to clinical, research, or other practice. Although not always sufficiently comprehensive to serve as state-of-the-art reviews, many of the individual chapters are very well referenced and could serve as excellent starting points on unfamiliar subjects.
